Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan

BACKGROUND: Addressing the global burden of multidrug-resistant tuberculosis (MDR-TB) requires identification of shorter, less toxic treatment regimens. Médecins Sans Frontières (MSF) is currently conducting a phase II/III randomised controlled clinical trial, to find more effective, shorter and tol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wharton-Smith, Alexandra, Horter, Shona, Douch, Emma, Gray, Nell, James, Nicola, Nyang’wa, Bern-Thomas, Singh, Jatinder, Nusratovna, Parpieva Nargiza, Tigay, Zinaida, Kazounis, Emil, Allanazarova, Gulayim, Stringer, Beverley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645116/
https://www.ncbi.nlm.nih.gov/pubmed/34863253
http://dx.doi.org/10.1186/s13063-021-05850-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645116/
https://www.ncbi.nlm.nih.gov/pubmed/34863253
http://dx.doi.org/10.1186/s13063-021-05850-0

Ejemplares similares